In its 2025 full year and fourth-quarter earnings call, Merck executives touted the merits of recent deals and what CEO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results